Literature DB >> 7570932

Severe outcomes of allogeneic and autologous blood donation: frequency and characterization.

M A Popovsky1, B Whitaker, N L Arnold.   

Abstract

BACKGROUND: There are few published data on severe outcomes of the donation of blood for allogeneic or autologous use. It would be helpful if blood collectors could better characterize and/or predict the likelihood of significant complications of blood donation. STUDY DESIGN AND METHODS: Very severe outcome (VSO) was defined as an event requiring hospitalization. Approximately 4.1 million American Red Cross whole-blood donation records (July 1993-March 1994) were reviewed for the incidence and type of VSO.
RESULTS: A total of 33 VSOs occurred for all donations. The incidence of VSOs for allogeneic donation was 1 (0.0005%) in 198,119 and that for autologous donation was 1 (0.006%) in 16,783 (p < 0.001). First-time donors were three times as likely to have a VSO. Donors > 40 years old had 87.9 percent of the VSOs, and donors > 60 years old had 48.5 percent. Vasovagal (66.7%) and anginal (12.1%) episodes were the most frequent complications, and 66.7 percent of reactions occurred at the blood collection site. The mean hospital stay was 1.9 days.
CONCLUSION: VSO is an infrequent complication of all types of blood donation, but its occurrence may be associated with significant morbidity and cost. VSO is nearly 12 times as likely in autologous blood donors.

Entities:  

Mesh:

Year:  1995        PMID: 7570932     DOI: 10.1046/j.1537-2995.1995.35996029156.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  20 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil.

Authors:  Thelma T Gonçalez; Ester C Sabino; Karen S Schlumpf; David J Wright; Silvana Leao; Divaldo Sampaio; Pedro L Takecian; Anna B Proietti; Anna B Proitetti; Edward Murphy; Michael Busch; Brian Custer
Journal:  Transfusion       Date:  2011-11-11       Impact factor: 3.157

Review 3.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

Review 4.  [Foreign blood saving measures in orthopedic surgery].

Authors:  P Reize; N Wülker
Journal:  Orthopade       Date:  2007-06       Impact factor: 1.087

5.  Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.

Authors:  Isabella Crocco; Massimo Franchini; Giovanni Garozzo; Anna Rosa Gandini; Giorgio Gandini; Pietro Bonomo; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

6.  Donor Hemovigilance with Blood Donation.

Authors:  Ulrich Diekamp; Johannes Gneißl; Angela Rabe; Stephan T Kießig
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

7.  Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis.

Authors:  Hisakazu Nishimori; Nobuharu Fujii; Keiko Fujii; Tohru Ikeda; Naomi Asano; Hiroaki Ogo; Miwa Yamakawa; Naoe Takagi; Fumio Otsuka; Kazuma Ikeda
Journal:  Int J Hematol       Date:  2017-03-07       Impact factor: 2.490

8.  Assessment of liver stiffness measurement: novel intraoperative blood loss predictor?

Authors:  Min-Soo Kim; Jeong-Rim Lee
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

9.  [Preoperative autologous blood donation in cardiac surgery. Reduction of allogeneic blood requirements].

Authors:  W Dietrich; R Busley; M Kriner
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

10.  The effect of tranexamic acid in blood loss and transfusion volume in adolescent idiopathic scoliosis surgery: a single-surgeon experience.

Authors:  Marios G Lykissas; Alvin H Crawford; Gilbert Chan; Lori A Aronson; Mohammed J Al-Sayyad
Journal:  J Child Orthop       Date:  2013-02-28       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.